Cost Effectiveness and Resource Allocation (May 2021)
Correction to: Cost-effectiveness evaluation of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine for children in Taiwan
Abstract
An amendment to this paper has been published and can be accessed via the original article.